Abstract
Traditional Chinese herbal drugs have been used for thousands of years in Chinese pharmacopoeia. The bark of Magnolia officinalis Rehder & E. Wilson, known under the pinyin name “Houpo”, has been traditionally used in Chinese and Japanese medicines for the treatment of anxiety, asthma, depression, gastrointestinal disorders, headache, and more. Moreover, Magnolia bark extract is a major constituent of currently marketed dietary supplements and cosmetic products. Much pharmacological activity has been reported for this herb and its major compounds, notably antioxidant, anti-inflammatory, antibiotic and antispasmodic effects. However, the mechanisms underlying this have not been elucidated and only a very few clinical trials have been published. In vitro and in vivo toxicity studies have also been published and indicate some intriguing features. The present review aims to summarize the literature on M. officinalis bark composition, utilisation, pharmacology, and safety.
概要
中草药已在中国药典中使用了数千年。木兰属的厚朴,主要用于治疗焦虑、哮喘、抑郁症、胃肠道疾病、头痛。其树皮提取物是目前市售的食品补充剂和化妆品的主要成分。厚朴及其主要成分具有多种药理活性,具有抗氧化、抗炎、抗生素和抗痉挛作用。然而,相关机制尚未明确,临床试验也鲜有报道。体外和体内毒性研究已经发现了一些有趣的特征。本文旨在总结关于厚朴的成分、利用、药理学和安全性的文献。
Similar content being viewed by others
References
Agosta, C., Atlante, M., Benvenuti, C., 2011. Randomized controlled study on clinical efficacy of isoflavones plus Lactobacillus sporogenes, associated or not with a natural anxiolytic agent in menopause. Minerva Ginecol., 63(1):11–17.
AHA, 2016. American Heart Association. http://www.heart.org/HEARTORG
Ahn, K.S., Sethi, G., Shishodia, S., et al., 2006. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-κB activation pathway. Mol. Cancer Res., 4(9):621–633. http://dx.doi.org/10.1158/1541-7786.MCR-06-0076
Alexeev, M., Grosenbaugh, D.K., Mott, D.D. et al., 2012. The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABAA receptors. Neuropharmacology, 62(8):2507–2514. http://dx.doi.org/10.1016/j.neuropharm.2012.03.002
Amblard, F., Govindarajan, B., Lefkove, B., et al., 2007. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorg. Med. Chem. Lett., 17(16):4428–4431. http://dx.doi.org/10.1016/j.bmcl.2007.06.024
Arora, S., Singh, S., Piazza, G.A., et al., 2012. Honokiol: a novel natural agent for cancer prevention and therapy. Curr. Mol. Med., 12(10):1244–1252. http://dx.doi.org/10.2174/156652412803833508
Bang, K.H., Kim, Y.K., Min, B.S., et al., 2000. Antifungal activity of magnolol and honokiol. Arch. Pharm. Res., 23(1):46–49. http://dx.doi.org/10.1007/BF02976465
Bielory, L., Russin, J., Zuckerman, G., 2004. Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma. Allergy Asthma Proc., 5(5):283–291.
Boustie, J., Stigliani, J., Montanha, J., et al., 1998. Antipoliovirus structure-activity relationships of some aporphine alkaloids. J. Nat. Prod., 61(4):480–484. http://dx.doi.org/10.1021/np970382v
Buettner, R., Mora, L.B., Jove, R., 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res., 8(4):945–954.
Bunel, V., Antoine, M.H., Stévigny, C., et al., 2016. New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity. Food Chem. Toxicol., 87:77–87. http://dx.doi.org/10.1016/j.fct.2015.11.020
Chan, S., Zhao, M., Lao, L., et al., 2008. Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated Guinea pig ileum. Planta Med., 74(4):381–384. http://dx.doi.org/10.1055/s-2008-1034320
Chang, B., Lee, Y., Ku, Y., et al., 1998. Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms. Planta Med., 64(4):367–369. http://dx.doi.org/10.1055/s-2006-957453
Chang, H.M., But, P.P.H., 1986. Pharmacology and Applications of Chinese Materia-Medica (Volume I). Word Scientific, Philadelphia. http://dx.doi.org/10.1142/0284
Chang, H.M., But, P.P.H., 1987. Pharmacology and Applications of Chinese Materia Medica (Volume II). Word Scientific, Philadelphia. http://dx.doi.org/10.1142/0377
Chen, C.R., Zhou, X.Z., Luo, Y.J., et al., 2012. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABAA receptor in mice. Neuropharmacology. 63(6):1191–1199. http://dx.doi.org/10.1016/j.neuropharm.2012.06.031
Chen, F., Wang, T., Wu, Y.F., et al., 2004. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J. Gastroenterol., 10(23):3459–3463. http://dx.doi.org/10.3748/wjg.v10.i23.3459
Chen, Y.H., Lin, S.J., Chen, Y.L., et al., 2006. Antiinflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc. Haematol. Disord., 6(4):279–304. http://dx.doi.org/10.2174/187152906779010737
Choi, M.S., Lee, S.H., Cho, H.S., et al., 2007. Inhibitory effect of obovatol on nitric oxide production and activation of NF-κB/MAP kinases in lipopolysaccharide-treated RAW 264.7 cells. Eur. J. Pharmacol., 556(1–3):181–189. http://dx.doi.org/10.1016/j.ejphar.2006.10.054
Coleman, J.W., 2001. Nitric oxide in immunity and inflammation. Int. Immunopharmacol., 1(8):1397–1406. http://dx.doi.org/10.1016/S1567-5769(01)00086-8
Council of Europe, 2013. European Pharmacopoeia 8.1. Council of Europe, Strasbourg, p.3949-3950.
CPC (Chinese Pharmacopoeia Commission), 2010. Pharmacopoeia of the People’s Republic of China (English Edition). China Medical Science Press, Beijing, China.
Cui, W., Wang, Y., Chen, Q., et al., 2013. Magnolia extract (BL153) ameliorates kidney damage in a high fat dietinduced obesity mouse model. Oxid. Med. Cell. Longev., 2013:367040. http://dx.doi.org/10.1155/2013/367040
Curran, T., Franza, B.J., 1988. Fos and Jun: the AP-1 connection. Cell, 55(3):395–397. http://dx.doi.org/10.1016/0092-8674(88)90024-4
Davis, T.L., 1981. Chemistry of Magnolia grandiflora L. University of Florida.
Dharmananda, S., 2002. Safety Issues Affecting Chinese Herbs: Magnolia alkaloids. Institute for Traditional Medicine, Oregon. http://www.itmonline.org/arts/magsafe.htm EPCNF
(European Parliament Concerning Novel Foods and Novel Food Ingredients), 2009. Application for the Approval of Magnolia Bark Supercritical Carbon Dioxide Extract (MBSE) from Magnolia officinalis. The William Wrigley Jr. Company, Chicago.
Fazel, M., 1995. Now show me your tongue: a taste of medicine in China. Lancet, 346(8991–8992):1687–1688. http://dx.doi.org/10.1016/S0140-6736(95)92847-2
Ferrero-Miliani, L., Nielsen, O.H., Andersen, P.S., et al., 2007. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin. Exp. Immunol., 147(2):227–235. http://dx.doi.org/10.1111/j.1365-2249.2006.03261.x
Fried, L.E., Arbiser, J.L., 2009. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid. Redox Signal., 11(5):1139–1148. http://dx.doi.org/10.1089/ars.2009.2440
Garcia, X., Stein, F., 2006. Nitric oxide. Semin. Pediatr. Infect. Dis., 17(2):55–57. http://dx.doi.org/10.1053/j.spid.2006.04.002
Garg, A., Aggarwal, B.B., 2002. Nuclear transcription factor-κB as a target for cancer drug development. Leukemia, 16(6):1053–1068. http://dx.doi.org/10.1038/sj.leu.2402482
Garrison, R., Chambliss, W.G., 2006. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Altern. Ther. Health Med., 12(1):50–54.
Grivennikov, S., Karin, M., 2010. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalkin cancer. Cytokine Growth Factor Rev., 21(1):11–19. http://dx.doi.org/10.1016/j.cytogfr.2009.11.005
Guertin, D.A., Sabatini, D.M., 2007. Defining the role of mTOR in cancer. Cancer Cell, 12(1):9–22. http://dx.doi.org/10.1016/j.ccr.2007.05.008
Guo, Z., Wang, X.B., Luo, J.G., et al., 2011. A novel aporphine alkaloid from Magnolia officinalis. Fitoterapia, 82(4):637–641. http://dx.doi.org/10.1016/j.fitote.2011.01.021
Hahm, E.R., Singh, S.V., 2007. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol. Cancer Ther., 6(10):2686–2695. http://dx.doi.org/10.1158/1535-7163.MCT-07-0217
Hellstrom, M.K., Ramberg, P., 2014. The effect of a dentifrice containing Magnolia extract on established plaque and gingivitis in man: a six-month clinical study. Int. J. Dent. Hyg., 12(2):96–102. http://dx.doi.org/10.1111/idh.12047
Herlaar, E., Brown, Z., 1999. p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today, 5(10):439–447. http://dx.doi.org/10.1016/S1357-4310(99)01544-0
Herrmann, D., Schreiber, A., Ciotkowska, A., et al., 2014. Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death. Prostate Int., 2(3):140–146. http://dx.doi.org/10.12954/PI.14055
Ho, J.H.C., Hong, C.Y., 2012. Cardiovascular protection of magnolol: cell-type specificity and dose-related effects. J. Biomed. Sci., 19:70. http://dx.doi.org/10.1186/1423-0127-19-70
Ho, K.Y., Tsai, C.C., Chen, C.P., et al., 2001. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother. Res., 15(2):139–141. http://dx.doi.org/10.1002/ptr.736
Hoi, C.P., Ho, Y.P., Baum, L., et al., 2010. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res., 24(10):1538–1542. http://dx.doi.org/10.1002/ptr.3178
Homma, M., Oka, K., Kobayashi, H., et al., 1993. Impact of free magnolol excretions in asthmatic patients who responded well to Saiboku-To, a Chinese herbal medicine. J. Pharm. Pharmacol., 45(9):844–846. http://dx.doi.org/10.1111/j.2042-7158.1993.tb05699.x
Hon, K.L., Fung, C.K., Leung, A.K., et al., 2015. Complementary and alternative medicine for childhood asthma: an overview of evidence and patents. Recent Pat. Inflamm. Allergy Drug Discov., 9(1):66–79. http://dx.doi.org/10.2174/1872213X09666150302105225
Hu, J., Gao, W.Y., Ling, N.S., et al., 2009. Antidiarrhoeal and intestinal modulatory activities of Wei-Chang-An-Wan extract. J. Ethnopharmacol., 125(3):450–455. http://dx.doi.org/10.1016/j.jep.2009.07.027
Hu, Y., Qiao, J., Zhang, X., et al., 2011. Antimicrobial effect of Magnolia officinalis extract against Staphylococcus aureus. J. Sci. Food Agric., 91(6):1050–1056. http://dx.doi.org/10.1002/jsfa.4280
International Agency for Research on Cancer, 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr. Eval. Carcinog. Risks Hum., 82:1–556.
Iwasaki, K., Wang, Q., Seki, H., et al., 2000. The effects of the traditional Chinese medicine Banxia Houpo Tang on the swallowing reflex in Parkinson’s disease. Phytomedicine, 7(4):259–263. http://dx.doi.org/10.1016/S0944-7113(00)80042-2
Jeong, S.I., Kim, Y.S., Lee, M.Y., et al., 2009. Regulation of contractile activity by magnolol in the rat isolated gastrointestinal tracts. Pharmacol. Res., 59(3):183–188. http://dx.doi.org/10.1016/j.phrs.2008.11.008
Kalman, D.S., Feldman, S., Feldman, R., et al., 2008. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr. J., 7:11. http://dx.doi.org/10.1186/1475-2891-7-11
Kang, J.S., Lee, K.H., Han, M.H., et al., 2008. Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother. Res., 22(7):883–888. http://dx.doi.org/10.1002/ptr.2386
Karin, M., 2006. NF-κB and cancer: mechanisms and targets. Mol. Carcinog., 45(6):355–361. http://dx.doi.org/10.1002/mc.20217
Kaushik, G., Ramalingam, S., Subramaniam, D., et al., 2012. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. Am. J. Surg., 204(6):868–873. http://dx.doi.org/10.1016/j.amjsurg.2012.09.001
Kim, B.H., Cho, J.Y., 2008. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmol. Sin., 29(1):113–122. http://dx.doi.org/10.1111/j.1745-7254.2008.00725.x
Kim, S.Y., Kim, J., Jeong, S.I., et al., 2015. Antimicrobial effects and resistant regulation of magnolol and honokiol on methicillin-resistant Staphylococcus aureus. Biomed. Res. Int., 2015:283630. http://dx.doi.org/10.1155/2015/283630
Kim, Y.J., Choi, M.S., Cha, B.Y., et al., 2013. Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. Mol. Nutr. Food Res., 57(11):1988–1998. http://dx.doi.org/10.1002/mnfr.201300113
Kimura, I., Chui, L.H., Fujitani, K., et al., 1989. Inotropic effects of (±)-higenamine and its chemically related components, (+)-R-coclaurine and (+)-S-reticuline, contained in the traditional sino-Japanese medicines “Bushi” and “Shin-i” in isolated guinea pig papillary muscle. Jpn. J. Pharmacol., 50(1):75–78. http://dx.doi.org/10.1254/jjp.50.75
Ko, C.H., Chen, H.H., Lin, Y.R., et al., 2003. Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea. Planta Med., 69(6):532–536. http://dx.doi.org/10.1055/s-2003-40654
Koetter, U., Barrett, M., Lacher, S., et al., 2009. Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors. J. Ethnopharmacol., 124(3):421–425. http://dx.doi.org/10.1016/j.jep.2009.05.040
Kong, Z.L., Tzeng, S.C., Liu, Y.C., 2005. Cytotoxic neolignans: an SAR study. Bioorg. Med. Chem. Lett., 15(1):163–166. http://dx.doi.org/10.1016/j.bmcl.2004.10.011
Kumar, A., Singh, U.K., Chaudhary, A., 2013. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med. Chem., 5(7):809–829. http://dx.doi.org/10.4155/fmc.13.32
Lee, B., Kim, C.H., Moon, S.K., 2006. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett., 580(22):5177–5184. http://dx.doi.org/10.1016/j.febslet.2006.08.064
Lee, D.H., Szczepanski, M.J., Lee, Y.J., 2009. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J. Cell. Biochem., 106(6):1113–1122. http://dx.doi.org/10.1002/jcb.22098
Lee, J.W., Lee, Y.K., Lee, B.J., et al., 2010. Inhibitory effect of ethanol extract of Magnolia officinalis and 4-Omethylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol. Biochem. Behav., 95(1):31–40. http://dx.doi.org/10.1016/j.pbb.2009.12.003
Lee, S.K., Chun, H.K., Yang, J.Y., et al., 2007. Inhibitory effect of obovatal on the migration and invasion of HT1080 cells via the inhibition of MMP-2. Bioorg. Med. Chem., 15(12):4085–4090. http://dx.doi.org/10.1016/j.bmc.2007.03.081
Lee, S.Y., Cho, J.S., Yuk, D.Y., et al., 2009. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-κB. J. Pharm. Sci., 111(2):124–136. http://dx.doi.org/10.1254/jphs.09048FP
Lee, Y.J., Lee, Y.M., Lee, C.K., et al., 2011. Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther., 130(2):157–176. http://dx.doi.org/10.1016/j.pharmthera.2011.01.010
Lee, Y.S., Choi, S.S., Yonezawa, T., et al., 2015. Honokiol, magnolol, and a combination of both compounds improve glucose metabolism in high-fat diet-induced obese mice. Food Sci.Biotechnol., 24(4):1467–1474. http://dx.doi.org/10.1007/s10068-015-0189-6
Li, H.B., Yi, X., Gao, J.M., et al., 2007. Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch. Pharm. Res., 30(12):1566–1574. http://dx.doi.org/10.1007/BF02977326
Li, L., Han, W., Gu, Y., et al., 2007. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res., 67(10):4894–4903. http://dx.doi.org/10.1158/0008-5472.CAN-06-3818
Li, N., Song, Y., Zhang, W., et al., 2007. Evaluation of the in vitro and in vivo genotoxicity of magnolia bark extract. Regul. Toxicol. Pharmacol., 49(3):154–159. http://dx.doi.org/10.1016/j.yrtph.2007.06.005
Lim, Y., Kwon, J.S., Kim, D.W., et al., 2010. Obovatol from Magnolia obovata inhibits vascular smooth muscle cell proliferation and intimal hyperplasia by inducing p21Cip1. Atherosclerosis, 210(2):372–380. http://dx.doi.org/10.1016/j.atherosclerosis.2009.11.037
Lin, S.I., Tsai, T.H., Chou, Y.J., et al., 2015. Characteristics associated with utilization of asthma-related traditional Chinese medicine services among asthma children in Taiwan: a nationwide cohort study. Evid. Based Complement. Alternat. Med., 2015:108961. http://dx.doi.org/10.1155/2015/108961
Lin, S.P., Tsai, S.Y., Chao, P.D.L., et al., 2011. Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats. Planta Med., 77(16):1800–1805. http://dx.doi.org/10.1055/s-0030-1271159
Lin, S.Y., Chang, Y.T., Liu, J.D., et al., 2001. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol. Carcinog., 32(2):73–83. http://dx.doi.org/10.1002/mc.1066
Lin, Y.R., Chen, H.H., Ko, C.H., et al., 2007. Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci., 81(13):1071–1078. http://dx.doi.org/10.1016/j.lfs.2007.08.014
Liu, H., Zang, C., Emde, A., et al., 2008. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur. J. Pharmacol., 591(1–3):43–51. http://dx.doi.org/10.1016/j.ejphar.2008.06.026
Liu, X., Wang, Q., Song, G., et al., 2014. The classification and application of toxic Chinese materia medica. Phytother. Res., 28(3):334–347. http://dx.doi.org/10.1002/ptr.5006
Liu, Z., Zhang, X., Cui, W., et al., 2007. Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Regul. Toxicol. Pharmacol., 49(3):160–171. http://dx.doi.org/10.1016/j.yrtph.2007.06.006
Lo, Y.C., Teng, C.M., Chen, C.F., et al., 1994. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem. Pharmacol., 47(3):549–553. http://dx.doi.org/10.1016/0006-2952(94)90187-2
Lu, Y.C., Chen, H.H., Ko, C.H., et al., 2003. The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus. Naunyn-Schmiedeberg’s Arch. Pharmacol., 368(4):262–269. http://dx.doi.org/10.1007/s00210-003-0802-8
Maruyama, Y., Kuribara, H., 2000. Overview of the pharmacological features of honokiol. CNS Drug Rev., 6(1):35–44. http://dx.doi.org/10.1111/j.1527-3458.2000.tb00136.x
Maruyama, Y., Kuribara, H., Morita, M., et al., 1998. Identification of magnolol and honokiol as anxiolytic agents in extracts of Saiboku-To, an oriental herbal medicine. J. Nat. Prod., 61(1):135–138. http://dx.doi.org/10.1021/np9702446
Mohamed, S.M., Hassan, E.M., Ibrahim, N.A., 2010. Cytotoxic and antiviral activities of aporphine alkaloids of Magnolia grandiflora L. Nat. Prod. Res., 24(15):1395–1402. http://dx.doi.org/10.1080/14786410902906959
Mucci, M., Carraro, C., Mancino, P., et al., 2006. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol., 58(4):323–334.
Munroe, M.E., Arbiser, J.L., Bishop, G.A., 2007. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol., 179(2):753–763. http://dx.doi.org/10.4049/jimmunol.179.2.753
Nachtergael, A., Poivre, M., Belayew, A., et al., 2015. In vitro genotoxicity tests point to an unexpected and harmful effect of a Magnolia and Aristolochia association. J. Ethnopharmacol., 174:178–186. http://dx.doi.org/10.1016/j.jep.2015.07.045
Nakazawa, T., Yasuda, T., Ohsawa, K., 2003. Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice. J. Pharm. Pharmacol., 55(11):1583–1591. http://dx.doi.org/10.1211/0022357022188
NCBI (National Center for Biotechnology Information), 2016. PubChem Compound Database. http://pubchem.ncbi.nlm.nih.gov
Newton, K., Dixit, V.M., 2012. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol., 4(3):a006049. http://dx.doi.org/10.1101/cshperspect.a006049
Ngezahayo, J., Havyarimana, F., Hari, L., et al., 2015. Medicinal plants used by Burundian traditional healers for the treatment of microbial diseases. J. Ethnopharmacol., 173:338–351. http://dx.doi.org/10.1016/j.jep.2015.07.028
Ngezahayo, J., Pottier, L., Ribeiro, S.O., et al., 2016. Plastotoma rotundifolium aerial tissue extract has antibacterial activities. Ind. Crops Prod., 86:301–310. http://dx.doi.org/10.1016/j.indcrop.2016.04.004
Okusa, P.N., Stévigny, C., Névraumont, M., et al., 2014. Ferulaldehyde and lupeol as direct and indirect antimicrobial compounds from Cordia gilletii (Boraginaceae) root barks. Nat. Prod. Commun., 9(5):619–622.
Ou, H.C., Chou, F.P., Lin, T.M., et al., 2006. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Chem.-Biol. Interact., 161(1):1–13. http://dx.doi.org/10.1016/j.cbi.2006.02.006
Ouédraogo, M., Baudoux, T., Stévigny, C., et al., 2012. Review of current and “omics” methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms. J. Ethnopharmacol., 140(3):492–512. http://dx.doi.org/10.1016/j.jep.2012.01.059
Park, C.S., Kim, T.B., Lee, J.Y., et al., 2012. Effects of add-on therapy with NDC-052, an extract from Magnoliae flos, in adult asthmatic patients receiving inhaled corticosteroids. Korean J. Intern. Med., 27(1):84–90. http://dx.doi.org/10.3904/kjim.2012.27.1.84
Park, J., Lee, J., Jung, E., et al., 2004. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur. J. Pharmacol., 496(1–3):189–195. http://dx.doi.org/10.1016/j.ejphar.2004.05.047
Pearson, G., Robinson, F., Gibson, T.B., et al., 2001. Mitogenactivated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev., 22(2):153–183. http://dx.doi.org/10.1210/er.22.2.153
Porciani, P.F., Grandini, S., 2012. The effect of zinc acetate and magnolia bark extract added to chewing gum on volatile sulfur-containing compounds in the oral cavity. J. Clin. Dent., 23(3):76–79.
Porciani, P.F., Grandini, S., Chazine, M., 2014. The effect of zinc lactate and magnolia bark extract added tablets on volatile sulfur-containing compounds in the oral cavity. J. Clin. Dent., 25(3):53–56.
Pyo, M.K., Yun-Choi, H.S., Hong, Y.J., 2003. Antiplatelet activities of aporphine alkaloids isolated from leaves of Magnolia obovata. Planta Med., 69(3):267–269. http://dx.doi.org/10.1055/s-2003-38493
Rasamiravaka, T., Vandeputte, O.M., Pottier, L., et al., 2014. Pseudomonas aeruginosa biofilm formation and persistence, along with the production of quorum sensing dependent virulence factors, are disrupted by a triterpenoid coumarate ester isolated from Dalbergia trichocarpa, a tropical legume. PLoS ONE, 10(7):e0132791. http://dx.doi.org/10.1371/journal.pone.0132791
Ricciardolo, F.L., Sterk, P.J., Gaston, B., et al., 2004. Nitric oxide in health and disease of the respiratory system. Physiol. Rev., 84(3):731–765. http://dx.doi.org/10.1152/physrev.00034.2003
Sheu, M.L., Liu, S.H., Lan, K.H., 2007. Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth. PLoS ONE, 2(10):e1096. http://dx.doi.org/10.1371/journal.pone.0001096
Shih, C.Y., Chou, T.C., 2012. The antiplatelet activity of magnolol is mediated by PPAR-β/γ. Biochem. Pharmacol., 84(6):793–803. http://dx.doi.org/10.1016/j.bcp.2012.06.022
Simmonds, R.E., Foxwell, B.M., 2008. Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation. Rheumatology (Oxford), 47(5):584–590. http://dx.doi.org/10.1093/rheumatology/kem298
Sohn, E.J., Kim, C.S., Kim, Y.S., et al., 2007. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci., 80(5):468–475. http://dx.doi.org/10.1016/j.lfs.2006.09.037
Syu, W.J., Shen, C.C., Lu, J.J., et al., 2004. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem. Biodivers., 1(3):530–537. http://dx.doi.org/10.1002/cbdv.200490046
Tachikawa, E., Takahashi, M., Kashimoto, T., 2000. Effects of extract and ingredients isolated from Magnolia obovata Thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem. Pharmacol., 60(3):433–440. http://dx.doi.org/10.1016/S0006-2952(00)00343-9
Tang, J.L., Liu, B.Y., Ma, K.W., 2008. Traditional Chinese medicine. Lancet, 372(9654):1938–1940. http://dx.doi.org/10.1016/S0140-6736(08)61354-9
Taniguchi, C., Homma, M., Takano, O., et al., 2000. Pharmacological effects of urinary products obtained after treatment with saibokuto, a herbal medicine for bronchial asthma, on type IV allergic reaction. Planta Med., 66(7):607–611. http://dx.doi.org/10.1055/s-2000-8626
Teng, C.M., Chen, C.C., Ko, F.N., et al., 1988. Two antiplatelet agents from Magnolia officinalis. Thromb. Res., 50(6):757–765. http://dx.doi.org/10.1016/0049-3848(88)90336-2
Teschke, R., Wolff, A., Frenzel, C., et al., 2014. Review article: herbal hepatotoxicity—an update on traditional Chinese medicine preparations. Aliment. Pharmacol. Ther., 40(1):32–50. http://dx.doi.org/10.1111/apt.12798
Teschke, R., Zhang, L., Long, H., et al., 2015. Traditional Chinese medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann. Hepatol., 14(1):7–19.
Teschke, R., Larrey, D., Melchart, D., et al., 2016. Traditional Chinese medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines, 3(3):18. http://dx.doi.org/10.3390/medicines3030018
Tripathi, P., Kashyap, L., Singh, V., 2007. The role of nitric oxide in inflammatory reactions. FEMS Immunol. Med. Microbiol., 51(3):443–452. http://dx.doi.org/10.1111/j.1574-695X.2007.00329.x
Unschuld, P.U., 1999. The past 1000 years of Chinese medicine. Lancet, 354:SIV9. http://dx.doi.org/10.1016/S0140-6736(99)90352-5
Vanherweghem, J.L., Depierreux, M., Tielemans, C., et al., 1993. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet, 341(8842):387–391. http://dx.doi.org/10.1016/0140-6736(93)92984-2
Wang, J.P., Hsu, M.F., Raung, S.L., et al., 1992. Antiinflammatory and analgesic effects of magnolol. Naunyn-Schmiedeberg’s Arch. Pharmacol., 346(6):707–712. http://dx.doi.org/10.1007/BF00168746
Wang, S., Li, Y., 2005. Traditional Chinese medicine. In: Devinsky, O., Pacia, S., Shachter, S. (Eds.), Complementary and Alternative Therapies for Epilepsy. Demos Medical Publishing, New York, p.177–182.
Wang, T., Chen, F., Chen, Z., et al., 2004. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J. Gastroenterol., 10(15):2205–2208.
Waymire, J.C., 1997. Chapter 12: Biogenic Amine Neurotransmitters. University of Texas Medical School at Houston. http://neuroscience.uth.tmc.edu/s1/chapter12.html
WHO (World Health Organization), 2016. World Health Statistics 2016: Monitoring Health for the SDGs. World Health Organization, Geneva.
Williamson, E.M., Chan, K., Xu, Q., et al., 2015. Integrated toxicological approaches to evaluating the safety of herbal medicine. Science, 347(6219 Suppl.):S47–S49.
Wisdom, R., 1999. AP-1: one switch for many signals. Exp. Cell Res., 253(1):180–185. http://dx.doi.org/10.1006/excr.1999.4685
Wittchen, H.U., Hoyer, J., 2001. Generalized anxiety disorder: nature and course. J. Clin. Psychiatr., 62(Suppl. 11):15–21.
Woodbury, A., Yu, S.P., Wei, L., et al., 2013. Neuromodulating effects of honokiol: a review. Front. Neurol., 4:130. http://dx.doi.org/10.3389/fneur.2013.00130
Xu, Q., Bauer, R., Hendry, B.M., et al., 2013. The quest for modernisation of traditional Chinese medicine. BMC Complement. Altern. Med., 13:132. http://dx.doi.org/10.1186/1472-6882-13-132
Yan, R., Wang, W., Guo, J., et al., 2013. Studies on the alkaloids of the bBark of Magnolia officinalis: isolation and on-line analysis by HPLC-ESI-MSn. Molecules, 18(7):7739–7750. http://dx.doi.org/10.3390/molecules18077739
Yang, H.Y., Chen, C.F., 1997. Subacute toxicity of 15 commonly used Chinese drugs (II). J. Food Drug. Anal., 5(4):355–380.
Yang, S.E., Hsieh, M.T., Tsai, T.H., et al., 2002. Downmodulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiolinduced apoptosis in human squamous lung cancer CH27 cells. Biochem. Pharmacol., 63(9):1641–1651. http://dx.doi.org/10.1016/S0006-2952(02)00894-8
Yang, S.E., Hsieh, M.T., Tsai, T.H., et al., 2003. Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br. J. Pharmacol., 138(1):193–201. http://dx.doi.org/10.1038/sj.bjp.0705024
Young, I.S., Woodside, J.V., 2001. Antioxidants in health and disease. J. Clin. Pathol., 54(3):176–186. http://dx.doi.org/10.1136/jcp.54.3.176
Yu, C., Meyer, D., Campbell, G., et al., 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science, 269(5220):81–83. http://dx.doi.org/10.1126/science.7541555
Yu, S.X., Yan, R.Y., Liang, R.X., et al., 2012. Bioactive polar compounds from stem bark of Magnolia officinalis. Fitoterapia, 83(2):356–361. http://dx.doi.org/10.1016/j.fitote.2011.11.020
Zaki, H.F., Abd-El-Fattah, M.A., Amina, S.A., 2014. Naringenin protects against scopolamine-induced dementia in rats. Bull. Fac. Pharm. Cairo Univ., 52(1):15–25. http://dx.doi.org/10.1016/j.bfopcu.2013.11.001
Zandi, R., Larsen, A.B., Andersen, P., et al., 2007. Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell. Signal., 19(10):2013–2023. http://dx.doi.org/10.1016/j.cellsig.2007.06.023
Zhang, B., Maniatis, T., Song, Y., et al., 2008. Evaluation of magnolia bark extract in chromosomal aberration assays. Mutat. Res.-Genet. Toxicol. Environ. Mutag., 654(2):133–137. http://dx.doi.org/10.1016/j.mrgentox.2008.05.009
Zhang, L., Yan, J., Liu, X., et al., 2012. Pharmacovigilance practice and risk control of TCM in China. J. Ethnopharmacol., 140(3):519–525. http://dx.doi.org/10.1016/j.jep.2012.01.058
Zhang, P., Liu, X., Zhu, Y., et al., 2013. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells. Neurosci. Lett., 534:123–127. http://dx.doi.org/10.1016/j.neulet.2012.11.052
Zhou, H.Y., Shin, E.M., Guo, L.Y., et al., 2008. Antiinflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-κB, JNK and p38 MAPK inactivation. Eur. J. Pharmacol., 586(1–3):340–349. http://dx.doi.org/10.1016/j.ejphar.2008.02.044
Zhu, Y., Niu, M., Chen, J., et al., 2016. Hepatobiliary and pancreatic: comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J. Gastroenterol. Hepatol., 31(8):1476–1482. http://dx.doi.org/10.1111/jgh.13323
Ziyaev, R., Shtonda, N.I., Sturua, M.D., et al., 1999. Alkaloids of some Magnolia species. Life Sci., 35(3):366–367.
Zuo, G.Y., Zhang, X.J., Han, J., et al., 2015. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillinresistant Staphylococcus aureus (MRSA). BMC Complement. Altern. Med., 15(1):425. http://dx.doi.org/10.1186/s12906-015-0938-3
Author information
Authors and Affiliations
Corresponding author
Additional information
ORCID: Pierre DUEZ, http://orcid.org/0000-0002-0484-1478
Compliance with ethics guidelines
Mélanie POIVRE and Pierre DUEZ declare that they have no conflict of interest.
This article does not contain any studies with human or animal subjects performed by any of the authors.
Rights and permissions
About this article
Cite this article
Poivre, M., Duez, P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J. Zhejiang Univ. Sci. B 18, 194–214 (2017). https://doi.org/10.1631/jzus.B1600299
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1600299